![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Batm Advanced Communications Ld | LSE:BVC | London | Ordinary Share | IL0010849045 | ORD ILS0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.60 | 20.00 | 20.80 | 20.60 | 20.60 | 20.60 | 24,833 | 10:11:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Communications Services, Nec | 122.83M | -193k | -0.0004 | -515.00 | 89.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/11/2022 16:46 | Cut down to 31p again at close. Frustrating | ![]() resistance1 | |
02/11/2022 10:34 | https://www.telegrap | ![]() kooba | |
02/11/2022 10:29 | BATM enters the field of venereal disease diagnosis. Estimates the market at $1 billion BATM will sign an agreement with the French research institute Bioaster to expand its phenal systems and allow it to identify and treat the field of venereal diseases without delay. Zvi Marom: "If the disease is not diagnosed in time, it leads to chronic pain and death." | ![]() wizzkid211 | |
31/10/2022 14:28 | This was on Telco Systems twitter the other day ...October 20th 2022 Of note is that they are sharing the booth with Advantech who sell Edgility enabled UCPE white boxes. Telco Systems @TelcoSystems Come visit us at the Network X event in Amsterdam! We are a partner on @Advantech 's booth. Get to know #Edgility, our innovative, open edge compute platform for automating the deployment, operation and life cycle management of IT services at scale. | ![]() fse | |
31/10/2022 09:55 | Telco tweet EDGILITY up for award.https://twitte | ![]() kooba | |
29/10/2022 20:47 | amen resistance biggest con ever pulled on mankind. Amazing how pneumonia deaths one of the major causes of illness and possible death were simply listed as Covid and pneumonia cases went to zero. Hopefully instant testing results that are comprehensive and accurate will prevent hysteric reactions. ADOR RCA systems will match them with a "correct" treatment also. | ![]() fse | |
29/10/2022 17:28 | As much as understand how C-19 positively impacts revenue and share price of BATM/Ador. I won’t be taking notice of any media Covid scare stories from now on. The ‘cure’ and subsequent economic fall out has proved so much more damaging. If only we knew this back in 2020. | ![]() resistance1 | |
29/10/2022 15:06 | We know a company that can help ! "The gaggle of new variants have been gaining ground against BA.5, which has dominated Covid-19 infections in the United States since July. BA.5 now accounts for 49.6% of new infections in this country. Two variants, BQ.1 and BQ.1.1, have been growing especially fast. At the beginning of October, each one accounted for about 1% of new infections in the United States, but they have been roughly doubling in prevalence each week. Together, they now account for more than 1 in 4 new Covid-19 infections nationwide, according to CDC data. BQ.1 is causing about 14% of new infections; BQ.1.1. is causing 13% of new infections. BA.4.6 is causing another 10%. BF.7 accounts for 7.5% of newly diagnosed Covid-19. A slew of other new variants accounts for smaller pieces of the Covid-19 pie. These variants are not evenly distributed across the US. BQ.1.1 is now causing about 1 in 5 new Covid-19 infections in the Northeast, where cases and hospitalizations are rising. But that strain is causing just 3% of new Covid-19 infections in the Pacific Northwest. These variants are slightly different from each other, but they all carry some of the same key mutations that help them skirt immunity from vaccines and past infections. This makes them more likely to lead to breakthrough infections and reinfections." | ![]() fse | |
28/10/2022 20:59 | Let's see what happens on the TASE on Sunday... | ![]() paulisi | |
28/10/2022 17:54 | Great news, breaking the 30p barrier that has haunted us investors for so long is a big step. I think we will see new highs quite soon. | tradeterminator01 | |
28/10/2022 17:14 | Break out ?!!!! ;0) | ![]() gymratt | |
28/10/2022 17:02 | What? Actually closed UP at auction … 31p | ![]() resistance1 | |
27/10/2022 14:54 | Gymratt: You are very lucky and can look forward to a prosperous new year. If only I bought my holdings at these crazy low levels. However I'm sure that an upwards trend has now started and I will once again be in the profit zone soon. | ![]() resistance1 | |
27/10/2022 13:14 | TT1: I must correct you. THREE astronomical markets. You forgot Cybersecurity. | ![]() resistance1 | |
27/10/2022 13:11 | Resistance i agree, with BATM being present in two astronomical markets, i have no doubt that things will be looking very bright for the future of BATM and us bullish investors. | tradeterminator01 | |
27/10/2022 13:00 | Yet another reiteration from Shore Capital today. | ![]() resistance1 | |
27/10/2022 12:53 | From twitterTo date, we have developed meningitis & #respiratorydisease panels for ADOR's NATlab platform and are working with the Stop TB Partnership to develop a tuberculosis panel. This new collaboration will accelerate the development of an #STI panel. | ![]() paulisi | |
27/10/2022 12:30 | I believe the only company to cover in UK is the shop Shore Capital whilst they make forecasts and their comment is positive they do not set a target price. Zvi Marom the retiring CEO is on the board of Shore Capital . Unsure if there is any research out of Israel where they are also listed. | ![]() kooba | |
27/10/2022 12:26 | No volume today and no surprise if we see some market manipulation at the auction this evening with TASE closed tomorrow | ![]() paulisi | |
27/10/2022 11:31 | Taken a position here today. Looks like an interesting little company with a lot of potential. Are there any broker notes with target prices? | ![]() gymratt | |
27/10/2022 08:52 | Last night I shared market research that showed the Edge computing market will be worth $155bn by 2030. Looking up the lab testing market for diseases (excl Covid) the market is projected to be at least twice that in 2030. Two great markets to have products/services in for any company. | ![]() resistance1 | |
27/10/2022 08:43 | This is supposedly the kind of development that Israeli instos fancy in particular. Let's see if it generates some interest over there for a change. Meantime, the big buyer that has been frustratingly patient for weeks now is still very much around, while for the first time in forever, Shore Cap is showing the best bid in the market, though for smaller size. Maybe its nothing, but there has been a lot of noise from me and others that it's time Shore Cap wake the f up and show some support for this Company at these ridiculous levels, particularly as there is nothing I can see with nearly the same combination of undervaluation, fortress balance sheet and genuine, multiple growth prospects in their entire coverage universe. I still hope BATM fire their useless as*ses, but until that happens, the lazy pr1cks need to step up. Finally, 30p has emerged as something of an exaggerated resistance level. Let's see if we can bust through it today..... | ![]() echoridge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions